Summary of Significant Accounting Policies - Research and Development Tax Incentives (Details) € in Thousands, $ in Millions	11 Months Ended	12 Months Ended
Dec. 31, 2021 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2022 EUR (€)
Accounting Policies [Abstract]
Research and development tax credit \| $	$ (13.8)	$ (12.6)
Research and development tax credit limitation, expenditure on employees multiple		300.00%	300.00%
Research and development tax credit limitation, expenditure on employees additional Value \| €			€ 20

Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319

Name:	us-gaap_IncomeTaxReconciliationTaxCreditsResearch
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration